LRG1 might be a potential serum biomarker for early onset myocardial infarction, while a combined biomarker signature that included BNP (plasma brain natriuretic peptide) would be a more accurate predictor of heart failure than BNP alone (Xuan et al., 2019). Here, LRG1 is linked to myocardial infarction.